See the DrugPatentWatch profile for Adasuve
The price of Adasuve (sublingualfdtable for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults) is not publicly disclosed by its manufacturer, Verona Pharma. Pricing for prescription medications is typically determined by factors such as manufacturing costs, research and development expenses, market demand, and agreements with insurance providers and pharmacy benefit managers.
What is Adasuve used for?
Adasuve is a medication approved for the short-term treatment of acute agitation in adults diagnosed with schizophrenia or bipolar I disorder. It is administered as a tablet that dissolves under the tongue [1].
How is Adasuve administered?
Adasuve is a sublingual tablet, meaning it is placed under the tongue to dissolve. This method allows for rapid absorption into the bloodstream [1].
When did Adasuve receive approval?
Adasuve received FDA approval for its intended use in patients with schizophrenia and bipolar I disorder. Specific approval dates for these indications can be found through regulatory databases.
Are there alternatives to Adasuve for agitation?
Other treatment options exist for managing agitation in patients with schizophrenia and bipolar I disorder. These may include oral or injectable antipsychotic medications, benzodiazepines, and non-pharmacological interventions. The choice of treatment depends on individual patient factors, including the severity of agitation and underlying condition [2].
What are the risks associated with Adasuve?
A significant safety concern with Adasuve is the risk of bronchospasm, particularly in patients with respiratory conditions such as asthma or COPD [1][3]. Because of this risk, Adasuve is contraindicated in patients with these conditions and requires careful monitoring for respiratory symptoms during and after administration. Other potential side effects are also detailed in the prescribing information.
What is the patent status of Adasuve?
Information regarding the specific patents covering Adasuve and their expiration dates is available through resources like DrugPatentWatch.com. Patent protection grants market exclusivity for a period, after which generic or biosimilar versions may become available. For current patent information on Adasuve, you can consult DrugPatentWatch.com.
What companies are involved with Adasuve?
Verona Pharma is the manufacturer of Adasuve. The company is responsible for its development, marketing, and distribution.
How effective is Adasuve?
Clinical trials have demonstrated Adasuve's efficacy in rapidly reducing agitation in patients with schizophrenia and bipolar I disorder. Studies typically measure the change in agitation scales from baseline to specific time points after administration.
What are patient concerns about Adasuve?
Patient concerns may include the potential for side effects, particularly respiratory issues like bronchospasm. The rapid onset of action is a benefit, but understanding the full safety profile and appropriate usage is crucial for patients and their caregivers.
---
Sources:
1. DrugPatentWatch.com
2. Drug Information provided by manufacturer or prescribing information.
3. FDA Approved Labeling for Adasuve.